Live feed20:59:12·178dINSIDERFilingvia QuantisnowSVP, CHIEF ACCOUNTING OFFICER Calvin Sandra sold $296,080 worth of shares (7,402 units at $40.00), decreasing direct ownership by 16% to 38,233 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TVTX· Travere Therapeutics Inc.Health CareOriginal source
